About Blood Global Hematology

Quick Navigation

Launched in 2024, Blood Global Hematology is an open-access, peer-reviewed journal that aims to publish high-quality research, local adaptions of clinical guidelines, epidemiology and public health analyses, and opinion articles that address hematologic issues of global impact and aim to improve the lives of patients all over the world, with an emphasis on low- and middle-income countries. The journal is a focused space for dissemination of regional research, as well as research that involves global populations and international networks of collaborators. It will provide high-quality peer review and a supportive publication experience for authors, particularly those from regions currently underrepresented in the medical literature. As part of the Blood journals portfolio, Blood Global Hematology will connect to the ASH mission of educating hematologists worldwide to improve patient care.

With a long publishing history that demonstrates superior quality and reach, the Blood journals portfolio is a natural home for research in specialty areas of hematology. While all the Blood journals will continue to publish high-impact research from all over the world, Blood and Blood Advances are focused on publishing research of broad interest to all hematologists. Blood Global Hematology provides a space within the Blood Journals portfolio for research that will have a big influence within a localized setting or with a focus on a generalizable global impact.

Journal Scope

Blood Global Hematology aims to provide an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology research that address issues of global reach or with a global focus. Examples of this journal’s scope include:

• Healthcare delivery challenges in low- and middle-income countries
• Clinical cases that provide important insights into disease biology, diagnosis, or management
• Adaptations of medical guidelines for regional applicability
• Smaller-scale observational studies
• Prospective studies using novel approaches to Blood disorders that optimize resources
• Description of care-delivery systems
• Population health studies and analyses

 Journal Scientific Categories

• Clinical Trials and Observations 
• Epidemiology of Hematologic Diseases 
• Gene Therapy
• Global Collaborations
• Health Services and Outcomes 
• Hematopoiesis and Stem Cells
• Immunobiology and Immunotherapy
• Lymphoid Neoplasia
• Myeloid Neoplasia 
• Novel Approaches and Inventive Solutions 
• Phagocytes, Granulocytes, and Myelopoiesis
• Plasma Cell Disorders 
• Platelets and Thrombopoiesis 
• Population Health Studies 
• Public Policy, Health Care Delivery, and Resource Utilization
• Red Cells, Iron, and Erythropoiesis 
• Thrombosis and Hemostasis 
• Transfusion Medicine 
• Transplantation 
• Vascular Biology

Frequently Asked Questions for Blood Global Hematology

Is there a submission fee?

There are no submission fees for Blood Global Hematology.


When does a paper qualify for a discounted article publication fee?

Waivers and discounts for the publication fee will be applied based on the country of the corresponding author’s institutional affiliation. The fee will be waived for authors from institutions in low-income countries and authors from institutions in middle-income countries will receive a discount based on the gross national income of the country.
More information on this pricing method is available here.


Are there subscriptions fees to access the content of the journal?

Blood Global Hematology is an open access, online-only journal. Content is freely accessible to anyone worldwide.


What is the peer review process for submitted articles?

Articles that pass an initial editorial evaluation will receive a peer review report from at least two, typically three, external peer reviewers. Our intent is to ensure that the perspective of local experts is part of each evaluation when possible.


Will language editing support be available for authors?

Yes, we are committed to ensuring that the best science is published in the Blood journals regardless of English language proficiency. The Blood journals portfolio currently has a relationship with the language editing service Enago to help support authors with English language writing assistance and we are considering other ways to expand that support.